Medications and Pregnancy

Isn’t It Time for Stricter Valproic Acid Warnings for Women of Reproductive Age?

Despite FDA warnings, valproate is still prescribed to women of reproductive age, placing children at risk for birth defects and neurodevelopmental disorders.

By |2026-01-11T12:02:35-04:00October 14th, 2025|Medications and Pregnancy, Neurodevelopmental Disorders, Pregnancy Outcomes|Comments Off on Isn’t It Time for Stricter Valproic Acid Warnings for Women of Reproductive Age?

Beyond the FDA Panel: Medical Experts Reaffirm the Safety and Essential Role of SSRIs for Perinatal Mental Health

The recent FDA expert panel focused largely on the risks of SSRIs during pregnancy; however, medical organizations and experts support the important role of SSRIs and other medications in supporting maternal mental health.

By |2025-10-09T10:59:45-04:00October 9th, 2025|Medications and Pregnancy, Psychiatric Disorders During Pregnancy|Comments Off on Beyond the FDA Panel: Medical Experts Reaffirm the Safety and Essential Role of SSRIs for Perinatal Mental Health

Essential Reads: Prenatal Exposure to Valproate and Risk of Neurodevelopmental Disorders in Offspring

Prenatal exposure to valproate is linked to increased risk of autism spectrum disorder, ADHD, lower IQ, and intellectual disability, especially at higher doses.

By |2025-10-09T10:59:46-04:00September 30th, 2025|Essential Reads, Medications and Pregnancy|Comments Off on Essential Reads: Prenatal Exposure to Valproate and Risk of Neurodevelopmental Disorders in Offspring

Essential Reads: Why All Women of Reproductive Age Should Take Folic Acid

Folic Acid Awareness Week (Sept 7–14, 2025) focuses on the importance of daily folic acid supplements for women to prevent birth defects, as diet alone is often insufficient.

By |2025-10-09T10:59:49-04:00September 9th, 2025|Medications and Pregnancy, Psychiatric Disorders During Pregnancy, Risk of Malformations|Comments Off on Essential Reads: Why All Women of Reproductive Age Should Take Folic Acid

Information for Patients: How to Interpret the Recent FDA Panel on SSRIs and Pregnancy

The recent FDA expert panel focused largely on the risks of SSRIs during pregnancy but ignored or diminished the risks associated with untreated depression in the mother. 

By |2025-10-09T10:59:51-04:00August 14th, 2025|Antidepressants, Medications and Pregnancy, Psychiatric Disorders During Pregnancy|Comments Off on Information for Patients: How to Interpret the Recent FDA Panel on SSRIs and Pregnancy
Go to Top